Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations.

MLA

Liquori, Christina L., et al. “Mutations in a Gene Encoding a Novel Protein Containing a Phosphotyrosine-Binding Domain Cause Type 2 Cerebral Cavernous Malformations.” American Journal of Human Genetics, vol. 73, no. 6, Dec. 2003, pp. 1459–64. EBSCOhost, https://doi.org/10.1086/380314.

APA

Liquori, C. L., Berg, M. J., Siegel, A. M., Huang, E., Zawistowski, J. S., Stoffer, T., Verlaan, D., Balogun, F., Hughes, L., Leedom, T. P., Plummer, N. W., Cannella, M., Maglione, V., Squitieri, F., Johnson, E. W., Rouleau, G. A., Ptacek, L., & Marchuk, D. A. (2003). Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. American Journal of Human Genetics, 73(6), 1459–1464. https://doi.org/10.1086/380314

Chicago

Liquori, Christina L, Michel J Berg, Adrian M Siegel, Elizabeth Huang, Jon S Zawistowski, T’Prien Stoffer, Dominique Verlaan, et al. 2003. “Mutations in a Gene Encoding a Novel Protein Containing a Phosphotyrosine-Binding Domain Cause Type 2 Cerebral Cavernous Malformations.” American Journal of Human Genetics 73 (6): 1459–64. doi:10.1086/380314.